invar in 15 minutes · to get rid of nail fungus and strengthen nails restoring health and beauty...
TRANSCRIPT
ENABLING
MILLIONS
OF RUSSIANS
TO LIVE HEALTHIER
LIVES
www.invar.ru
Corporate presentation 2017
INVAR in 15 minutes
2
About Company
• Development Stages
• Vision and Strategy
• Corporate Culture
• Structure
• Management
• Geographic Reach
2016 Results
• Company Rating
• Financial Results
Product portfolio of the company
• Product manufacture geography
• Advantages of the products
CONTENT
3
• Development Stages
• Vision and Strategy
• Corporate Culture
• Structure
• Management
• Geographic Reach
ABOUT COMPANY
4
We are in a continuous development
2013
Focus on OTC retail market
1991
Company
foundation
2000
National business coverage INVAR 1994
Opening
of "Pharma"
direction
2006
Focus on original innovative products
INVAR is a national pharmaceutical
company.
We are focused on Women’s health and
Self-Medication.
We market 6 brands from the Great
Britain, Spain and the Netherlands.
2018
INVAR is the OTC market leader
in selected segments
(strategic focus)
5
Strategy Shifting full focus to the strategic profile of end consumer and increasing the importance of
the company on the Russian OTC market as a recognizable and established expert in
addressing the needs and solving the problems of the end consumer in key target
audiences - B2B (retail) and B2C (end consumers).
Mission: Enabling millions of Russians to live healthier lives.
Vision: Developing Leadership INVAR is a No.1 OTC company in Russia with own brands in selected consumer niches.
We have a clear vision and strategy
6
INVAR is a company with results-oriented corporate culture
Openness
Transparency
Following
the development strategy
Clarity of tasks
Fair business conduct
Work
within legal framework
Professionalism
Customer focus
Market analysis
Innovations
Process automation
WIN-WIN
Our Values:
FOCUS ON
RESULT DRIVE
LEADERSHIP PROACTIVENESS
7
Commercial Division
Marketing Division
Supply
Division
Supply Chain
Management
department
Business
Develop
ment
Marketing Sales
Division
HR
department
Medical
department
Maintenance
department
BI
Legal
department
IT
Finance and
accounting
department
Efficient management structure
8
INVAR’s Management
Alex Vaintrub
President
Larisa Mochalova
BU Director
Zlata Polishchuk
Executive Director
Vadim Nekrasov
Strategic Development
Director
Svetlana Titova
Medical Director
9
Geographic Reach
Moscow
NorthWest
Ural
Volga
South
Centre Siberia
Caring for improvement of human health,
company makes medicines available in all
federal districts of Russia
Far East
10
2016 Results • Company Rating
• Financial Results
11
Invar ranked among TOP-50 pharmaceutical
companies by its sales
INVAR ranks 49th in the rating of OTC medicine among pharmaceutical companies in Russia according to
the data of the marketing agency DSM Group, retail audit 2016
ТОР- 50
12
Company share in OTC Russian market in 2016 – 0.54%*
* According to the data of the marketing agency DSM Group, retail audit 2010-2016
2010 2011 2012 2013 2014 2015 2016
0,38% 0,45% 0,52% 0,72% 0,91% 0,79% 0,54%
0,00%
0,10%
0,20%
0,30%
0,40%
0,50%
0,60%
0,70%
0,80%
0,90%
1,00%
2010 2011 2012 2013 2014 2015 2016
13
Position on competitive markets – TOP 10*
COMPETITIVE MARKETS
Market
CAGR
2013-2016
Market
growth
2016
Market volume
2016 mln rub
Brand value
turnover on
the market
2016, mln
rub.
Brand value
market
share, % rub.
2016
Market
leader
value
share, %
rub.
Evolution
Index
Market
position
Atopy-predisposed problem
skin
(Skin-cap gel) -26,3% 27,6% 233,5
2,3 1% 37% 0,85 12
Chronical dermatosis (Skin-
cap pharma) 3,1% -4,5% 7 579,2
827,1 11% 33% 0,86 3
Onychomycosis (Mycosan) 4,5% 2,0% 5 915,5
407,6 7% 35% 0,62 5
Labial herpes (Erazaban) 682,5% -0,2% 1 087,7
45,6 4% 42% 1,19 4
Non-specific vulvovaginitis
(Fluomizin®) 10,2% 0,9% 4 271,1
177,6 4% 33% 0,88 8
Vaginal flora restoration
(Gynoflor® E) -4,3% -0,7% 1 165,5
181,6 16% 19% 0,82 4
Viral genital infections
(Epigen Intim spray 0,1%) 1,9% 0,6% 1 956,8
617,9 32% 32% 0,85 1
Intimate hygiene (Epigen
Intim gel) 12,4% 3,0% 931,9
256,1 27% 59% 0,85 2
Rhinosinusitis (Sinuforte®) -14,1% 5,3% 7 939,1
370,4 5% 23% 0,77 7
* According to the data of the marketing agency DSM Group, retail audit 2010-2016
14
In 2013-2016 Compound Annual Growth Rate
(CAGR) in monetary terms amounted to 12%*
* According to the data of Invar
693
1 018
1 344
1 930
2 777 2 704 2 714
47% 32% 44% 44% -3% 0%
-100%
-80%
-60%
-40%
-20%
0%
20%
40%
60%
80%
100%
-
500
1 000
1 500
2 000
2 500
3 000
2010 2011 2012 2013 2014 2015 2016 г.
Mln
. R
UB
Company sale development dynamics 2010-2016 in monetary terms
298 385 432 527 653 718 773 214
310 381
477
579
728 856
239
333
356
459
366
305
57
135
139
193 195
192
59
99
132
156
191
331
744 518 384
0
500
1 000
1 500
2 000
2 500
3 000
2010 2011 2012 2013 2014 2015 2016
Company brand sale development dynamics 2010-2016
Skin-cap Epigen Sinuforte Gynoflor
Fluomizin Mycosan Erazaban
15
In 2013-2016 Compound Annual Growth Rate (CAGR) in
real terms amounted to -1%*
* According to the data of Invar
1 097
1 644
2 077
3 149
4 500
3 337
3 080
50% 26% 52% 43% -26% -8%
-100%
-80%
-60%
-40%
-20%
0%
20%
40%
60%
80%
100%
-
1 000
2 000
3 000
4 000
5 000
2010 2011 2012 2013 2014 2015 2016 г.
Th
s. u
nit
s Company sale development dynamics 2010-2016
in real terms
399 513 547 630 747 632 644
471
643 726 836
971 1 003 1 053
230 284
285
361 225 173
149
302 281
368
274 256 210
304
360
295 338
808
1 609
831 575
0
500
1 000
1 500
2 000
2 500
3 000
3 500
4 000
4 500
5 000
2010 2011 2012 2013 2014 2015 2016
Company brand sale development dynamics 2010-2016
Skin-cap Epigen Sinuforte Gynoflor
Fluomizin Mycosan Erazaban
16
TOP-figures 2016
Turnover 2 728 mln. rub. in 2016
Share of the overall OTC-market turnover –
0.54 %*
Growth 2016/2015
-17% in rub.,
-21% in units
* According to the data of the marketing agency DSM Group, retail audit 2008-2016
17
Product portfolio of the company • Product manufacture geography
• Advantages of the products
18
Product manufacture geography
Spain
The Inited Kingdom
The Netherlands
The United Kingdom
Erazaban
Spain
SKIN-CAP
Epigen Intim
The Netherlands
Mycosan
INVAR forms its product portfolio based on long-term agreements.
Company partners are leading European drug developers and
manufacturers: Chemigroup France S.A., Fleet Laboratories Limited,
Serrix B.V.
19
www.mycosan.ru
* There are contraindications. Before application it is necessary to consult with the expert
LET YOUR NAILS BE HEALTHY AND
BEAUTIFUL!
Mycosan – the unique kit that helps to get rid of nail
fungus and strengthen nails*
Through deep penetration into close nail
structure, double blockade of fungal cell and
barrier film formation on the surface, Mycosan
promotes the growth of healthy nail
Mycosan – the kit that at the same time helps
to get rid of nail fungus and strengthen nails
restoring health and beauty of your nails
20
Erazaban helps to quickly get rid of
manifestations of labial herpes - itching,
burning, pain
Erazaban in case of early treatment,
prevents vesication and crust formation
Composition: patented original
molecule Docosanol
www.erasaban.ru
* According to the patient leaflet the average recovery time is 4-6 days.
There are contraindications. Before application it is necessary to consult with the expert
ERAZABAN - QUICKER WAY TO
TREAT LABIAL HERPES
Erazaban - Product for treatment of labial herpes*
21
SKIN-CAP - IS A NONHORMONAL AID IN SKIN
INFLAMMATION, ITCHING AND REDNESS*
Triple mode of action
• anti-inflammatory
• anti-fungal
• anti-bacterial
Provides of dermatosis treatment without
hormones. A wide choice of forms allows
to pick up individually treatment at various
clinical manifestations.
www.skincap.ru
When the specified symptoms are caused
by psoriasis , atopic dermatitis, eczema,
neurodermatitis, skin dryness, seborrheic
dermatitis.
SKIN-CAP. NUMBER 1 ON
PROTECTION OF YOUR SKIN
* Number 1 brand by value sales in 2016 among brands, which contain Pyrithione zinc, according to the data
of DSM Group.
There are contraindications. Before application it is necessary to consult with the expert
22
Epigen Intim - a unique line based on activated
glycyrrhizic acid*
Therapeutic and preventive spray
(15 and 60 ml):
Treatment and prevention of genital
vaginal infections.*
Treatment and prevention of the
states which are followed by
decrease in local immunity
(nonspecific vulvovaginitis, candidal
vulvovaginitis, bacterial vaginosis.*
At the phenomena of discomfort,
itching, burning, dryness in genitals.
Daily intimate hygiene gel
(250 ml):
Maintains natural pH balance and
microflora of the intimate zone giving
a sensation of purity and freshness
www.epigen.ru
EPIGEN INTIM - YOUR INTIMATE
HABIT
* List of vaginal infections and therapy indicated in the patient leaflet.
There are contraindications. Before application it is necessary to consult with the expert
ENABLING
MILLIONS
OF RUSSIANS
TO LIVE HEALTHIER
LIVES
THANK YOU FOR ATTENTION!
57, Building 1A, Dubininskaya St., 115054
Phone/Fax: + 7 (495) 544-51-54